Brief: Promore Pharma Granted US Patent Regarding Treatment Of Chronic Wounds

PMD Device Solutions AB

08/12/2021 07:26

Dec 8 (Reuters) - Promore Pharma AB  PROMO.ST :
    * PROMORE PHARMA GRANTED US PATENT REGARDING TREATMENT OF
CHRONIC
WOUNDS
    * PATENT PERIOD EXTENDS UNTIL AT LEAST NOVEMBER 2034, WITH
POSSIBILITIES OF FURTHER PATENT EXTENSION.

Source text for Eikon:  ID:nMFN5zllCD 
Further company coverage:  PROMO.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))